Anti-pain effect assessment of intraperitoneal marcaine after laparoscopic sleeve gastrectomy

Assessing the effect of intraperitoneal marcaeine instillationin control of pain after laparascopic sleeve gastrectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016120329181N4

Enrollment

120

Registered

2017-02-09

Start date

2016-04-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity. Other Obesity

Interventions

Intervention 1: 1g acetaminophen intravenous every 6 hour and Diclofenac suppository every 8 hour in control group. Intervention 2: 30 cc Intraperitoneal marcaine instillation end of operation and 1g

Treatment - Drugs

1g acetaminophen intravenous every 6 hour and Diclofenac suppository every 8 hour in control group

30 cc Intraperitoneal marcaine instillation end of operation and 1g Acetaminophen every 6 hour and Diclofenac suppository every 8 hour in intervention group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria BMI more than 40 Exclusion criteria Untreatable cardiopulmonary disease;untreated addiction;untreated psychologic disorder

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: 6,12.24 hour after operation. Method of measurement: Pain scaling criteria in NRS.;Hospital stay time. Timepoint: once. Method of measurement: Patient record.	—

Secondary

Measure	Time frame
Nosocomial infection. Timepoint: First of study. Method of measurement: Report during 30 days.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasser Malekpour Alamdari

Shahid Beheshti University of Medical Sceinces

nassermalekpour@gmail.com+98 21 2207 4087

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 7, 2026